We previously showed that the cellular proteins ZEB1 and ZEB2/SIP1 both play key roles in regulating the latent-lytic switch of Epstein-Barr Virus (EBV) by repressing BZLF1 gene expression. We investigated here the effects of cellular microRNA (miRNA) 200 (miR200) family members on the EBV infection status of cells. We show that miR200b and miR429, but not miR200a, can induce EBV-positive cells into lytic replication by downregulating expression of ZEB1 and ZEB2, leading to production of infectious virus. The levels of miR200 family members in EBV-infected cells strongly negatively correlated with the levels of the ZEBs (e.g., ؊0.89 Reactivation of EBV out of latency into lytic replication is necessary for the viral progeny to pass from host to host. It occurs naturally in infected individuals at a low frequency; periodic shedding of the virus into saliva allows for transmission (75). It remains unclear how reactivation occurs in vivo. The product of the BZLF1 gene, known as BZLF1 (also called ZEBRA, Z, Zta, and EB1), is a key player in switching EBV from latency into lytic replication in cells in culture (16,17,25,80; reviewed in references 74 and 75).BZLF1 is a multifunctional DNA-binding protein belonging to the bZIP member of transcription factors (12). By activating transcription of other viral genes and binding to the viral origin of lytic replication, oriLyt, BZLF1 can induce viral genome replication and expression of a cascade of other EBV lytic genes necessary for packaging of the genome into virion particles and exit from the host cell (40,52,74,76,77). BZLF1 can also interact with several cellular proteins, affecting their activities and cellular localization, further contributing to viral reactivation (61, 74). Because of BZLF1's central role in reactivation of EBV out of latency into lytic replication, factors that regulate its expression have been implicated as potential therapeutics for treating patients with EBV-associated malignancies.Our laboratory previously reported that the cellular proteins ZEB1 (also known as ␦EF1, TCF8, AREB6, ZFHEP, NIL-2A, ZFHX1A, and BZP) and ZEB2 (also known as SIP1, SMA-DIP1, ZFHX1B, and KIAA0569) can both bind to a sequence element, termed ZV, located within the BZLF1 promoter, Zp (22,47,48,92); a second element, ZVЈ, synergizes with the ZV element for higher-affinity binding of the ZEBs to Zp via their two zinc fingers (Fig. 1A) (X. Yu, P. McCarthy, D. Gorlen, and J. E. Mertz, unpublished data). Both of these ZEB family members bind to target DNA via E-box-binding sequences resembling 73). Depending on interactions with coactivators and corepressors and associations with histone deacetylases (HDACs) (68,71,84), ZEB1 can either activate or repress transcription of its target genes (68,70,72); to date, ZEB2 has been reported only to repress transcription (67). We showed that exogenous expression of either ZEB1 or ZEB2 leads to repression of transcription driven from Zp in transient transfection assays (22,48,92). Mutation of the ZV element in the context of the B9...